| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:3143.)
© 2002 American Heart Association, Inc.
ATP III Final Report PDF |
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
Related Article:
- Primary Prevention of Cardiovascular Disease: A Call to Action
- Robert O. Bonow
Circulation 2002 106: 3140-3141.[Full Text]
This article has been cited by other articles:
 |
|
 |
|
  D. Mozaffarian, A. Kamineni, R. J. Prineas, and D. S. Siscovick Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study Arch Intern Med, May 12, 2008; 168(9): 969 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bahrami, D. A. Bluemke, R. Kronmal, A. G. Bertoni, D. M. Lloyd-Jones, E. Shahar, M. Szklo, and J. A.C. Lima Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1775 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Kitzmiller, J. M. Block, F. M. Brown, P. M. Catalano, D. L. Conway, D. R. Coustan, E. P. Gunderson, W. H. Herman, L. D. Hoffman, M. Inturrisi, et al. Managing Preexisting Diabetes for Pregnancy: Summary of evidence and consensus recommendations for care Diabetes Care, May 1, 2008; 31(5): 1060 - 1079. [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Konstantinova, G. S. Tell, S. E. Vollset, O. Nygard, O. Bleie, and P. M. Ueland Divergent Associations of Plasma Choline and Betaine with Components of Metabolic Syndrome in Middle Age and Elderly Men and Women J. Nutr., May 1, 2008; 138(5): 914 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A. Ludovica Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, and S. Fargion Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis Diabetes, May 1, 2008; 57(5): 1355 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Wenger Current Status of Cardiac Rehabilitation J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1619 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Guyton, B. G. Brown, S. Fazio, A. Polis, J. E. Tomassini, and A. M. Tershakovec Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1564 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Van Gaal, A. J. Scheen, A. M. Rissanen, S. Rossner, C. Hanotin, O. Ziegler, and for the RIO-Europe Study Group Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study Eur. Heart J., April 15, 2008; (2008) ehn076v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Smith, S. B. Malkowicz, F. Chu, J. Forrest, P. Sieber, K. G. Barnette, D. Rodriquez, and M. S. Steiner Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study J. Clin. Oncol., April 10, 2008; 26(11): 1824 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Betteridge, R. A. DeFronzo, and R. J. Chilton PROactive: time for a critical appraisal Eur. Heart J., April 2, 2008; 29(8): 969 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Porrini, P. Delgado, A. Alvarez, M. Cobo, L. Perez, J. M. Gonzalez-Posada, L. Hortal, R. Gallego, J. J. Garcia, M. Checa, et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1436 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Negron, M. Molina, A. Mayor, V. Rodriguez, and L. Vila Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico Lupus, April 1, 2008; 17(4): 348 - 354. [Abstract] [PDF]
|
|
|
|
|
|
R. R. Allen, L. Carson, C. Kwik-Uribe, E. M. Evans, and J. W. Erdman Jr Daily Consumption of a Dark Chocolate Containing Flavanols and Added Sterol Esters Affects Cardiovascular Risk Factors in a Normotensive Population with Elevated Cholesterol J. Nutr., April 1, 2008; 138(4): 725 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Grundy Metabolic Syndrome Pandemic Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 629 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wassertheil-Smoller, C. Kooperberg, A. P. McGinn, R. C. Kaplan, J. Hsia, S. L. Hendrix, J. E. Manson, J. S. Berger, L. H. Kuller, M. A. Allison, et al. Lipoprotein-Associated Phospholipase A2, Hormone Use, and the Risk of Ischemic Stroke in Postmenopausal Women Hypertension, April 1, 2008; 51(4): 1115 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A Edwards, J. M Bugaresti, and A. C Buchholz Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences Am. J. Clinical Nutrition, March 1, 2008; 87(3): 600 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tabara, H. Osawa, R. Kawamoto, R. Tachibana-Iimori, M. Yamamoto, J. Nakura, T. Miki, H. Makino, and K. Kohara Reduced High-Molecular-Weight Adiponectin and Elevated High-Sensitivity C-Reactive Protein Are Synergistic Risk Factors for Metabolic Syndrome in a Large-Scale Middle-Aged to Elderly Population: the Shimanami Health Promoting Program Study J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S-G Ahn, H-S Lim, D-Y Joe, S-J Kang, B-J Choi, S-Y Choi, M-H Yoon, G-S Hwang, S-J Tahk, and J-H Shin Relationship of epicardial adipose tissue by echocardiography to coronary artery disease Heart, March 1, 2008; 94(3): e7 - e7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Shirali and M. J. Bia Management of Cardiovascular Disease in Renal Transplant Recipients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M Backes, C. V Venero, C. A Gibson, J. F Ruisinger, P. A Howard, P. D Thompson, and P. M Moriarty Effectiveness and Tolerability of Every-Other-Day Rosuvastatin Dosing in Patients with Prior Statin Intolerance Ann. Pharmacother., March 1, 2008; 42(3): 341 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Grundy A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B16 - B23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Nesto and K. Mackie Endocannabinoid system and its implications for obesity and cardiometabolic risk Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B34 - B41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Haas The Role of the Diabetes Educator: Patient Case Scenarios The Diabetes Educator, March 1, 2008; 34(Supplement_2): 32S - 36S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hollander Cardiometabolic Risk Factors and Visceral Adipose Tissue The Diabetes Educator, March 1, 2008; 34(Supplement_2): 37S - 41S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Greenland and D. Lloyd-Jones Critical Lessons From the ENHANCE Trial JAMA, February 27, 2008; 299(8): 953 - 955. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vosough-Ghanbari, R. Rahimi, S. Kharabaf, S. Zeinali, A. Mohammadirad, S. Amini, N. Yasa, A. Salehnia, T. Toliat, S. Nikfar, et al. Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial Evid. Based Complement. Altern. Med., February 27, 2008; (2008) nen018v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Lutsey, L. M. Steffen, and J. Stevens Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study Circulation, February 12, 2008; 117(6): 754 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L Madsen, A. Rissanen, J. M Bruun, K. Skogstrand, S. Tonstad, D. M Hougaard, and B. Richelsen Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study Eur. J. Endocrinol., February 1, 2008; 158(2): 179 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Wessell, H. A. Liszka, P. J. Nietert, R. G. Jenkins, L. S. Nemeth, and S. Ornstein Achievable Benchmarks of Care for Primary Care Quality Indicators in a Practice-Based Research Network American Journal of Medical Quality, February 1, 2008; 23(1): 39 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 J. F. P. Berbee, S. P. Mooijaart, A. J. M. de Craen, L. M. Havekes, D. van Heemst, P. C. N. Rensen, and R. G. J. Westendorp Plasma Apolipoprotein CI Protects Against Mortality From Infection in Old Age J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 122 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.M. Ntyintyane, V.R. Panz, F.J. Raal, and G.V. Gill Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease QJM, February 1, 2008; 101(2): 111 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Esmaillzadeh and L. Azadbakht Consumption of Hydrogenated Versus Nonhydrogenated Vegetable Oils and Risk of Insulin Resistance and the Metabolic Syndrome Among Iranian Adult Women Diabetes Care, February 1, 2008; 31(2): 223 - 226. [Full Text] [PDF]
|
|
|
|
|
|
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato Primary Prevention of Cardiovascular Disease in People With Dysglycemia Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Van Gaal, X. Pi-Sunyer, J.-P. Despres, C. McCarthy, and A. Scheen Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program Diabetes Care, February 1, 2008; 31(Supplement_2): S229 - S240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Grundy Promise of Low-Density Lipoprotein-Lowering Therapy for Primary and Secondary Prevention Circulation, January 29, 2008; 117(4): 569 - 573. [Full Text] [PDF]
|
|
|
|
|
|
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
|
|
J. Avorn and N. K. Choudhry Using Computer-Based Decision Support to Close the "Know Do" Gap in Lipid-Lowering Therapy Circulation, January 22, 2008; 117(3): 336 - 337. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Oh, A. Malani, H. Ammar, S. Mughal, and J. D. Brunzell Hypertriglyceridemia. N. Engl. J. Med., January 17, 2008; 358(3): 310 - 310. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Grundy Thyroid mimetic as an option for lowering low-density lipoprotein PNAS, January 15, 2008; 105(2): 409 - 410. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Van den Bergh, A. Vanderper, P. Vangheluwe, F. Desjardins, I. Nevelsteen, W. Verreth, F. Wuytack, P. Holvoet, W. Flameng, J.-L. Balligand, et al. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness Cardiovasc Res, January 15, 2008; 77(2): 371 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Afilalo, G. Duque, R. Steele, J. W. Jukema, A. J.M. de Craen, and M. J. Eisenberg Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 37 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. deGoma, N. J. Leeper, and P. A. Heidenreich Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Wolever, A. L Gibbs, C. Mehling, J.-L. Chiasson, P. W Connelly, R. G Josse, L. A Leiter, P. Maheux, R. Rabasa-Lhoret, N W. Rodger, et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein Am. J. Clinical Nutrition, January 1, 2008; 87(1): 114 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Peters Clinical Relevance of Non-HDL Cholesterol in Patients With Diabetes Clin. Diabetes, January 1, 2008; 26(1): 3 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Nesto LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach? Clin. Diabetes, January 1, 2008; 26(1): 8 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Laughlin, E. Barrett-Connor, and J. Bergstrom Low Serum Testosterone and Mortality in Older Men J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 68 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Z. Fan, M. Russell, S. Stranges, J. Dorn, and M. Trevisan Association of Lifetime Alcohol Drinking Trajectories with Cardiometabolic Risk J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 154 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Natal, M. A. Fortuno, P. Restituto, A. Bazan, I. Colina, J. Diez, and N. Varo Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E52 - E60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Van Guilder, G. L. Hoetzer, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza Metabolic syndrome and endothelial fibrinolytic capacity in obese adults Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R39 - R44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Kabagambe, M. Y. Tsai, P. N. Hopkins, J. M. Ordovas, J. M. Peacock, I. B. Borecki, and D. K. Arnett Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study Clin. Chem., January 1, 2008; 54(1): 154 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al. Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study Circulation, January 1, 2008; 117(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Preis and C. J. O'Donnell Coronary Heart Disease Risk Assessment by Traditional Risk Factors and Newer Subclinical Disease Imaging: Is a "One-Size-Fits-All" Approach the Best Option? Arch Intern Med, December 10, 2007; 167(22): 2399 - 2401. [Full Text] [PDF]
|
|
|
|
|
|
A. Simon, G. Chironi, and J. Levenson Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals Eur. Heart J., December 2, 2007; 28(24): 2967 - 2971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Lemos, A. D. B. Jancikic, F. M. R. Sanches, D. M. Christofalo, S. A. Ajzen, M. H. Miname, R. D. Santos, F. C. Fachini, A. B. Carvalho, S. A. Draibe, et al. Pulse wave velocity a useful tool for cardiovascular surveillance in pre-dialysis patients Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3527 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gkrania-Klotsas and A.-E. Klotsas HIV and HIV treatment: effects on fats, glucose and lipids Br. Med. Bull., December 1, 2007; 84(1): 49 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Preiss and N. Sattar Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence Heart, December 1, 2007; 93(12): 1493 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Hirschler, M. I. Roque, M. L. Calcagno, C. Gonzalez, and C. Aranda Maternal Waist Circumference and the Prediction of Children's Metabolic Syndrome Arch Pediatr Adolesc Med, December 1, 2007; 161(12): 1205 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Preston, P. Harvey, O. Herfert, G. Dykstra, J. W. Jukema, F. Sun, and D. Gillen A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial J. Clin. Pharmacol., December 1, 2007; 47(12): 1555 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|